Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium

<b>Background:</b> Montelukast (MTK), a potent antagonist of cysteinyl leukotriene receptor 1, has shown therapeutic promise for the treatment of neuropsychiatric disorders. Delirium, a common complication in critically ill patients, lacks effective treatment. This study aims to explore...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Yuan Li, Meilin Zhang, Shengnan Zhang, Guoping Yang
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Subjects:
montelukast
delirium
leukotriene
critical illness
Online Access:https://www.mdpi.com/1424-8247/17/1/125

Internet

https://www.mdpi.com/1424-8247/17/1/125

Similar Items